| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |